|
|
Volumn 48, Issue 2, 2008, Pages 144-145
|
|
Communicating with the FDA: The "third rail" of a new model for drug development
a
|
|
Author keywords
Biomarkers; Communication; Drug development; FDA; Modeling and simulation
|
|
Indexed keywords
CLINICAL DECISION MAKING;
CLINICAL RESEARCH;
DRUG DESIGN;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG RESEARCH;
DRUG SAFETY;
FOOD AND DRUG ADMINISTRATION;
HEALTH PROGRAM;
NOTE;
CLINICAL TRIALS AS TOPIC;
DRUG APPROVAL;
GOVERNMENT REGULATION;
GUIDELINES AS TOPIC;
HUMANS;
INTERDISCIPLINARY COMMUNICATION;
INVESTIGATIONAL NEW DRUG APPLICATION;
LEGISLATION, DRUG;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 38349168789
PISSN: 00912700
EISSN: 15524604
Source Type: Journal
DOI: 10.1177/0091270007313560 Document Type: Note |
|
Times cited : (3)
|
|
References (0)
|
